Camber Capital Management LP Viatris Inc Transaction History

Camber Capital Management LP

$4.08 Billion
Q1 2024

A detailed history of Camber Capital Management LP transactions in Viatris Inc stock. As of the latest transaction made, Camber Capital Management LP holds 16,250,000 shares of VTRS stock, worth $172 Million. This represents 4.76% of its overall portfolio holdings.

Number of Shares

16,250,000

Previous 18,500,000 12.16%

Holding current value

$172 Million

Previous $200 Million 3.16%

% of portfolio

4.76%

Previous 5.11%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$11.27 - $13.53 $25.4 Million - $30.4 Million	-2,250,000 Reduced 12.16%	16,250,000 $194 Million
Q4 2023 Feb 14, 2024	SELL	$8.77 - $10.85 $13.2 Million - $16.3 Million	-1,500,000 Reduced 7.5%	18,500,000 $200 Million
Q3 2023 Nov 14, 2023	SELL	$9.59 - $11.35 $24 Million - $28.4 Million	-2,500,000 Reduced 11.11%	20,000,000 $197 Million
Q1 2023 May 15, 2023	BUY	$9.2 - $12.26 $23 Million - $30.7 Million	2,500,000 Added 12.5%	22,500,000 $216 Million
Q4 2022 Feb 14, 2023	SELL	$8.72 - $11.56 $87.2 Million - $116 Million	-10,000,000 Reduced 33.33%	20,000,000 $223 Million

Q3 2022 Nov 14, 2022	BUY	$8.48 - $11.13 $59.4 Million - $77.9 Million	7,000,000 Added 30.43%	30,000,000 $256 Million
Q1 2022 May 16, 2022	BUY	$9.81 - $15.4 $68.7 Million - $108 Million	7,000,000 Added 43.75%	23,000,000 $250 Million
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $48.4 Million - $58.7 Million	4,000,000 Added 33.33%	16,000,000 $216 Million
Q4 2020 Feb 16, 2021	BUY	$14.3 - $18.74 $172 Million - $225 Million	12,000,000 New	12,000,000 $225 Million

Others Institutions Holding VTRS

# of Institutions

1,094

Shares Held

945M

Call Options Held

3.49M

Put Options Held

2.6M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $12.9B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Camber Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Camber Capital Management LP with notifications on news.

Account

Camber Capital Management LP Viatris Inc Transaction History